# Study on the Combination Regimen of Dexamethasone Ifosfamide Cisplatin Etoposide in Patients With NK/T Cell Lymphoma

> **NCT00568607** · PHASE2 · UNKNOWN · sponsor: **Fudan University** · enrollment: 60 (estimated)

## Conditions studied

- Lymphoma

## Interventions

- **DRUG:** IFO, VP-16, DDP, DXM

## Key facts

- **NCT ID:** NCT00568607
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-03
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2010-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00568607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00568607, "Study on the Combination Regimen of Dexamethasone Ifosfamide Cisplatin Etoposide in Patients With NK/T Cell Lymphoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00568607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*